Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Viacava

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
BMJ Case Reports|December 29, 2020
Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safeDaniele Barbaro, Paola Lapi, Paolo Viacava, et al.
Veterinary Dermatology|July 6, 2007
Paraneoplastic alopecia associated with hepatocellular carcinoma in a catLaura Marconato, Francesco Albanese, Paolo Viacava, et al.
Veterinary Dermatology|December 20, 2005
Feline cutaneous and visceral necrotizing panniculitis and steatitis associated with a pancreatic tumourFabrizio Fabbrini, Pascal Anfray, Paolo Viacava, et al.
American Journal of Dentistry|March 25, 2006
Microvessel density and vascular endothelial growth factor (VEGF) expression in human radicular cystsFilippo Graziani, Michele Vano, Paolo Viacava, et al.
Endocrine Pathology|December 13, 2006
Microvessel density in human normal and neoplastic parathyroidsPaolo Viacava, Guido Bocci, Giovanni Fanelli, et al.
Oncogene|January 16, 2003
Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patientsSofia Honorio, Angelo Agathanggelou, Marcus Schuermann, et al.
Thyroid : Official Journal of the American Thyroid Association|August 17, 2006
ClC-5 does not affect megalin expression and function in the thyroidTanja Maritzen, Simonetta Lisi, Roberta Botta, et al.
Annals of Plastic Surgery|January 10, 2009
Merkel cell carcinoma of the lower extremity: report of four cases and new considerationsGiordano Giannotti, Davide Lazzeri, Paolo Viacava, et al.
Medical Oncology (Northwood, London, England)|May 13, 2024
Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinomaEnrico Sammarco, Martina Rossetti, Alessia Salfi, et al.
Anticancer Research|August 21, 2003
Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinomaAngiolo Gadducci, Paolo Viacava, Stefania Cosio, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
BMJ Case Reports|December 29, 2020
Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safeDaniele Barbaro, Paola Lapi, Paolo Viacava, et al.
Veterinary Dermatology|July 6, 2007
Paraneoplastic alopecia associated with hepatocellular carcinoma in a catLaura Marconato, Francesco Albanese, Paolo Viacava, et al.
Veterinary Dermatology|December 20, 2005
Feline cutaneous and visceral necrotizing panniculitis and steatitis associated with a pancreatic tumourFabrizio Fabbrini, Pascal Anfray, Paolo Viacava, et al.
American Journal of Dentistry|March 25, 2006
Microvessel density and vascular endothelial growth factor (VEGF) expression in human radicular cystsFilippo Graziani, Michele Vano, Paolo Viacava, et al.
Endocrine Pathology|December 13, 2006
Microvessel density in human normal and neoplastic parathyroidsPaolo Viacava, Guido Bocci, Giovanni Fanelli, et al.
Oncogene|January 16, 2003
Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patientsSofia Honorio, Angelo Agathanggelou, Marcus Schuermann, et al.
Thyroid : Official Journal of the American Thyroid Association|August 17, 2006
ClC-5 does not affect megalin expression and function in the thyroidTanja Maritzen, Simonetta Lisi, Roberta Botta, et al.
Annals of Plastic Surgery|January 10, 2009
Merkel cell carcinoma of the lower extremity: report of four cases and new considerationsGiordano Giannotti, Davide Lazzeri, Paolo Viacava, et al.
Medical Oncology (Northwood, London, England)|May 13, 2024
Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinomaEnrico Sammarco, Martina Rossetti, Alessia Salfi, et al.
Anticancer Research|August 21, 2003
Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinomaAngiolo Gadducci, Paolo Viacava, Stefania Cosio, et al.
Pageof 6